InvestorsHub Logo
Followers 37
Posts 6419
Boards Moderated 3
Alias Born 05/06/2014

Re: None

Friday, 10/07/2022 9:04:42 AM

Friday, October 07, 2022 9:04:42 AM

Post# of 144813
No surprise here. Expected this:

"CEO Kenneth L. Waggoner has stepped down from the position as CEO effective October 6, 2022. The Board has since appointed Joshua N. Silverman, a member of the Board, as interim CEO."

Below suggests to me they will eventually take it private and then take the cash after they reduce the shares O/S.. Just a matter of time.

"A significant part of these activities includes the continuation of its share repurchase program to repurchase up to $10 million worth of PharmaCyte outstanding stock."

until the review by the Business Review Committee and the Board is complete and the Board has determined the actions and plans to be implemented.

“In the meantime, the Company will explore additional opportunities to create new paths toward shareholder value and will provide relevant updates to shareholders as they become available,” concluded Mr. Silverman.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News